Application of Chromogranin A and Chromogranin B in Advanced Neuroendocrine Tumors

被引：0
|
作者：
Li, Yuanliang [1 ]
Tan, Huangying [2 ]
机构：
[1] Beijing Univ Chinese Med, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Beijing, Peoples R China
来源：
PANCREAS | 2020年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：475 / 475
页数：1
相关论文
共 50 条
  • [41] ASPECTS OF THE NEUROENDOCRINE CEREBELLUM: EXPRESSION OF SECRETOGRANIN II, CHROMOGRANIN A AND CHROMOGRANIN B IN MOUSE CEREBELLAR UNIPOLAR BRUSH CELLS
    Nunzi, M. G.
    Mugnaini, E.
    [J]. NEUROSCIENCE, 2009, 162 (03) : 673 - 687
  • [42] Evaluation of a novel immunoradiometric assay for chromogranin A (CgA) in neuroendocrine tumors (NETs)
    Seregni, E
    Ferrari, L
    Artale, S
    Rodari, M
    Ballablo, G
    Bajetta, E
    Bombardieri, E
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1194 - 1194
  • [43] Correlation of Serum Chromogranin A Change with Radiographic Response in Patients with Non-Functioning Advanced Neuroendocrine Tumors
    Cheng, Y.
    Sun, Z.
    Bai, C.
    Ying, H.
    Meng, C.
    [J]. NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 252 - 253
  • [44] Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas
    Qiao, Xin-Wei
    Qiu, Ling
    Chen, Yuan-Jia
    Meng, Chang-Ting
    Sun, Zhao
    Bai, Chun-Mei
    Zhao, Da-Chun
    Zhang, Tai-Ping
    Zhao, Yu-Pei
    Song, Yu-Li
    Wang, Yu-Hong
    Chen, Jie
    Lu, Chong-Mei
    [J]. BMC ENDOCRINE DISORDERS, 2014, 14
  • [45] Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum
    Woltering, Eugene A.
    Beyer, David T.
    Thiagarajan, Ramcharan
    Ramirez, Robert A.
    Wang, Yi-Zarn
    Ricks, M. Jennifer
    Boudreaux, J. Philip
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 222 (04) : 534 - 542
  • [46] Baseline chromogranin A and its dynamics are prognostic markers in gastroenteropancreatic neuroendocrine tumors
    Rogowski, Wojciech
    Wachula, Ewa
    Lewczuk, Anna
    Kolesinska-Cwikla, Agnieszka
    Izycka-Swieszewska, Ewa
    Sulzyc-Bielicka, Violetta
    Cwikla, Jaroslaw B.
    [J]. FUTURE ONCOLOGY, 2017, 13 (12) : 1069 - 1079
  • [47] Age is an independent Predictor of Chromogranin A Levels in Patients with pancreatic neuroendocrine Tumors
    Overheu, O.
    Gisder, D. M.
    Nopel-Dunnebacke, S.
    Janot, M.
    Uhl, W.
    Tannapfel, A.
    Reinacher-Schick, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 155 - 155
  • [48] Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients
    Chou, Wen-Chi
    Hung, Yu-Shin
    Hsu, Jun-Te
    Chen, Jen-Shi
    Lu, Chang-Hsien
    Hwang, Tsann-Long
    Rau, Kun-Ming
    Yeh, Kun-Yun
    Chen, Tse-Ching
    Sun, Chien-Feng
    [J]. NEUROENDOCRINOLOGY, 2012, 95 (04) : 344 - 350
  • [49] Change in Chromogranin A correlates with computed tomography imaging in pancreatic neuroendocrine tumors
    Jensen, K. H.
    Hilsted, L.
    Andersen, J. F. B.
    Mynster, T.
    Knigge, U.
    [J]. REGULATORY PEPTIDES, 2012, 177 : S22 - S22
  • [50] Association Between Chromogranin Expression and Clinicopathologic Features in Appendiceal Neuroendocrine Tumors
    Gertsen, Benjamin
    Findeis-Hosey, Jennifer
    Huber, Aaron
    Hao, Yansheng
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S551 - S552
12345